AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

PRISTINAMYCINE

7 registrations across 5 African markets— 5 active

Markets with PRISTINAMYCINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
PYOSTATINE 500MG COMPRIME PELLICULE SECABLE BOITE DE 16🇨🇮Côte d'IvoireSANOFI WINTHROP INDUSTRIE, GENTILLY, 82 AVENUE RASPAILexpiredSept 2025
PYOSTACINE 500
Comprimé pelliculé / 500 MG
🇹🇳TunisiaSANOFI-AVENTIS FRANCEexpiredNov 1994
PYOSTACINE
comprimé pelliculé / 500 mg
🇸🇳SenegalRHONE POULENC RORERactive
PYOSTACINE
COMPRIME PELLICULE SECABLE
🇲🇦Moroccoactive
PYOSTACINE® 500MG CP PELL BTE(2 X 8) SANOFI-AVENTIS
comprimé pelliculé 500mg
🇲🇬MadagascarSANOFI AVENTIS France 2active
PYOSTACINE
COMPRIME PELLICULE SECABLE
🇲🇦Moroccoactive
PYOSTACINE® 500MG CP PELL BTE(2 X 8) SANOFI-AVENTIS
comprimé pelliculé 500mg
🇲🇬MadagascarSANOFI AVENTIS France 2active

PRISTINAMYCINE in Africa — Regulatory Overview

PRISTINAMYCINE is registered across 5 African markets with 7 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Madagascar, Côte d'Ivoire, Senegal and 1 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 7 registrations, 5 (71%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.